REVIEW PAPER
THE MACULAR HOLE AFTER INTRAVITREAL INJECTIONS OF RANIBIZUMAB IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION – A CASE STUDY
Publication date: 2013-11-26
Medical Studies 2013;29(1):89-93
KEYWORDS
ABSTRACT
There are two forms of age-related macular degeneration (AMD), the dry one and the exudative one. The exudative form of AMD can be treated using repeated intravitreal injections of antibodies against vascular endothelial growth factor (VEGF).
Optical coherence tomography (OCT) of the retina is a standard examination in monitoring patients treated with ranibizumab due to an exudative form of AMD.
VEGF plays a key role in the development of choroidal neovascularization in the exudative form of AMD.
The subject-matter of our observation was to present the development of the macular hole after treatment of the exudative form of AMD through repeated intravitreal injections of ranibizumab.
Ranibizumab is an antibody against VEGF. This substance is registered for the treatment of the exudative form of AMD. Ranibizumab may produce focal sites with traction forces on the surface of the retina during the contraction of the choroidal neovascular membrane. Both of these effects may cause contraction and delamination of the retina causing the macular hole to form.
Optical coherence tomography (OCT) of the retina is a standard examination in monitoring patients treated with ranibizumab due to an exudative form of AMD.
VEGF plays a key role in the development of choroidal neovascularization in the exudative form of AMD.
The subject-matter of our observation was to present the development of the macular hole after treatment of the exudative form of AMD through repeated intravitreal injections of ranibizumab.
Ranibizumab is an antibody against VEGF. This substance is registered for the treatment of the exudative form of AMD. Ranibizumab may produce focal sites with traction forces on the surface of the retina during the contraction of the choroidal neovascular membrane. Both of these effects may cause contraction and delamination of the retina causing the macular hole to form.
REFERENCES (8)
1.
Stankiewicz A, Figurska M. Zwyrodnienie plamki związane z wiekiem. Przewodnik diagnostyki i terapii. Wydawnictwo Medyczne Termedia, Poznań 2010; 9–11.
2.
Mitchell P, Korobelnik JF, Lanzetta P et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmology 2010 Jan; 94(1): 2–13.
3.
Keane PA, Chang KT, Liakopoulos S et al. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular ADM. Retina 2009 May; 29(5): 592–600.
4.
Kański J. Okulistyka Kliniczna. Wydawnictwo Elsevier Urban & Partner, Wrocław 2009.
5.
Wylęgała E, Nowińska A, Teper S. Optyczna koherentna tomografia, t. 2. Wydawnictwo Górnicki, Wrocław 2010; 55–68.
6.
Clemens CR, Holz FG, Meyer CH. Macular hole formation in the presence of a pigment epithelial detachment after three consecutive intravitreal antivascular endothelial growth factor injections. J Ocul Pharmacology Ther 2010 Jun; 26(3): 297–299.
7.
Grigoropoulos V, Emfietzoglou J, Nikolaidis P. Full-Thickness macular hole after intravitreal injections of ranibizumab in a patient with retinal pigment epithelium detachment and tear. Eur J Ophthalmology 2010 Mar–Apr; 20(2): 469–472.
8.
Bolz M, Ritter M, Polak K et al. The role of Stratus OCT in anti-VEGF therapy. Qualitative and quantitative assessment of neovascular AMD. Ophthalmology 2008 Jul; 105(7): 650–655.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
